2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
One document
more
Stories about Krankheit
- 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
One documentmore - 7
Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021
One documentmore - 2
Lindis Biotech develops immunotherapy against bladder cancer
One documentmore Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins
One documentmore- 2
A higher omega-3 level apparently protects from dying from COVID-19
One documentmore - 3
World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools
One documentmore EUROEXPO Messe- und Kongress GmbH
LogiMAT 2021 in Stuttgart will not take place | Date postponed to March 2022.
One documentmore- 5
Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups
One documentmore - 2
Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools
One documentmore KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB
One documentmoreEUROEXPO Messe- und Kongress GmbH
2LogiMAT 2020 Canceled
One documentmoreInspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB
One documentmoreThe development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB
One documentmoreHigh investor density at the Pitch Day hosted by IZB
One documentmore
Previous12